Atlas Trials

Stage III Nasopharyngeal Carcinoma AJCC v8

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Nasopharyngeal Carcinoma AJCC v8

RecordFirmDate
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer (NCT06980038)National Cancer Institute (NCI)2026-05-27
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer (NCT06532279)NRG Oncology2025-06-23
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma (NCT06682442)University of California, San Francisco2025-03-18
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) (NCT06064097)National Cancer Institute (NCI)2024-06-25
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer (NCT04870840)M.D. Anderson Cancer Center2020-10-19
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150)M.D. Anderson Cancer Center2016-12-29

Track Stage III Nasopharyngeal Carcinoma AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.